How Can Network-Pharmacology Contribute to Antiepileptic Drug Development? [PDF]
Network-pharmacology is a field of pharmacology emerging from the observation that most clinical drugs have multiple targets, contrasting with the previously dominant magic bullet paradigm which proposed the search of exquisitely selective drugs. What is
Di Ianni, Mauricio Emiliano +1 more
core +1 more source
Memory and mood outcomes after anterior thalamic stimulation for refractory partial epilepsy
A. Tröster +3 more
semanticscholar +1 more source
Plasticity changes of molecular networks form a cellular learning process. Signaling network plasticity promotes cancer, metastasis, and drug resistance development. 55 plasticity‐related cancer drug targets are listed (20 having already approved drugs, 9 investigational drugs, and 26 being drug target candidates).
Márk Kerestély +5 more
wiley +1 more source
Pregabalin in the management of partial epilepsy
Amir M ArainVanderbilt University Medical Center, Department of Neurology, Nashville, TN, USAAbstract: Pregabalin is a new antiepileptic medication that works by binding to alpha 2 delta subunit of the voltage-dependent calcium channels present in ...
Amir M Arain
doaj
Low-grade glioneuronal tumour with novel molecular features associated with unusual partial epilepsy in a child. [PDF]
Lo YY, Malicki DM, Levy ML, Crawford JR.
europepmc +1 more source
Interictal epileptiform discharges in partial epilepsy: Neurobiologic mechanisms based on clinical and experimental evidence [PDF]
Marco de Curtis, Massimo Avoli
openalex +1 more source
Dissecting the genetic basis of comorbid epilepsy phenotypes in neurodevelopmental disorders. [PDF]
BACKGROUND:Neurodevelopmental disorders (NDDs) such as autism spectrum disorder, intellectual disability, developmental disability, and epilepsy are characterized by abnormal brain development that may affect cognition, learning, behavior, and motor ...
Amini, Hajar +7 more
core
This Perspective examines practical power solutions for wearable healthcare systems, highlighting the limits of standard batteries. It categorizes wearables into four domains—point‐of‐care diagnostics, episodic monitoring, continuous long‐term monitoring, and therapeutic platforms—and analyzes their power needs.
Seokheun Choi
wiley +1 more source
Corrigendum to: UNC13B variants associated with partial epilepsy with favourable outcome. [PDF]
europepmc +1 more source
Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy
V. Salanova +27 more
semanticscholar +1 more source

